Mubasher TV
Contact Us Advertising   العربية

Dallah Healthcare Company announces its invitation to its shareholders to attend the Ordinary General Assembly meeting (first meeting) by means of modern technology

DALLAH HEALTH 4004 3.01% 133.40 3.90
Element List Explanation
Introduction The Board of Directors of Dallah Healthcare Company is pleased to invite its shareholders to participate and vote in the General Assembly Meeting (the first meeting)
City and Location of the General Assembly's Meeting Riyadh - Head Office - By Means of Modern Technology
Hyperlink of the Meeting Location Click Here
Date of the General Assembly's Meeting 2025-05-28 Corresponding to 1446-12-01
Time of the General Assembly’s Meeting 19:30
Methodology of Convening the General Assembly’s Meeting Via modern technology means
Attendance Eligibility, Registration Eligibility, and Voting End As per the rules and regulations, any shareholder registered in the Company’s shareholders register at the Securities Depository Center Company (Edaa) as of the end of trading session preceding the General Assembly’s Meeting has the right to attend the General Assembly’s Meeting.

The right to register to attend the General Assembly’s Meeting ends at the time of convening the General Assembly’s Meeting. The attendees right to vote on the agenda items of the General Assembly’s Meeting ends upon the end of the vote tallying by the votes collection committee.

Quorum for Convening the General Assembly's Meeting According to Article 32 of the Company’s Bylaws, the meeting of the Ordinary General Assembly shall not be valid unless attended by shareholders representing at least a quarter of the company's capital . If this quorum is not met during the first meeting, a second meeting will be held within one hour of the scheduled time for the first meeting, The second meeting shall be valid regardless of the number of shares represented in it.
General Assembly Meeting Agenda 1- Review and discuss the Board of Directors’ report for the fiscal year ended 31 December 2024.

2- Review and discuss the financial statements for the fiscal year ended 31 December 2024.

3- Vote on the company’s external auditor’s report for the fiscal year ended 31 December 2024 after discussion.

4- Vote on discharging the Board members from liability for the fiscal year 2024.

5- Vote on appointing the company’s external auditor from among the nominated candidates based on the Audit Committee’s recommendation, to review and audit the financial statements for the second, third, and annual periods of the fiscal year 2025, and the first quarter of the fiscal year 2026, and to determine their fees.

6- Voting on the remuneration of the Board members in the amount of SAR 3,050,000 for the fiscal year ended on 31/12/2024.

7- Vote on the business and contracts concluded between the company and Eng. Tariq bin Othman Al Kasabi, in which he has a direct interest, related to a contract for the provision of management consulting services. The total transactions for 2024 amounted to SAR 1,319,736, with no preferential terms under the contract (Attached).

8- Vote on the business and contracts concluded between the company and Aljazira Capital, in which the Chairman, Eng. Tariq bin Othman Al Kasabi, has an indirect interest as Chairman of Aljazira Capital. These include management fees related to the Wahet Al-Nakheel Real Estate Fund, covering a five-year renewable term valued at SAR 5,000,000, shared equally among the unit holders, in addition to a one-time fund structuring fee of SAR 3,065,215, also shared equally among the unit holders. It is noted that there are no preferential terms under these contracts (Attached).

9- Vote on the business and contracts concluded between the company and ATS, in which the Chairman, Eng. Tariq bin Othman Al Kasabi, has an indirect interest as a partner, and where his son, Mr. Abdullah bin Tariq Al Kasabi, serves as Chairman of the company. The contract pertains to the provision of technical support services, with total transactions for 2024 amounting to SAR 6,635,617. It is noted that there are no preferential terms under the contract (Attached).

10- Vote on the business and contracts concluded between the company and Aljazira Capital, in which the Chairman, Eng. Tariq bin Othman Al Kasabi, has an indirect interest as Chairman of Aljazira Capital. The contract pertains to the provision of financial advisory services, with total transactions for 2024 amounting to SAR 40,000. It is noted that there are no preferential terms under the contract (Attached).

11- Vote on the business and contracts concluded between the company and Jude Al-Hala Company, in which the Vice Chairman, Mr. Mohiuddin bin Saleh Kamel, has a direct interest as a partner and board member. The contract pertains to the lease of a property, with total transactions for 2024 amounting to SAR 995,546. It is noted that there are no preferential terms under the contract (Attached).

12- Vote on the business and contracts concluded between the company and Darin Travel and Tourism Agency, in which the Vice Chairman, Mr. Mohiuddin bin Saleh Kamel, and Board Member, Mr. Amr bin Mohammed Kamel, have indirect interests. Mr. Mohiuddin bin Saleh Kamel serves as Vice Chairman of Al Baraka Holding Company, and Mr. Amr bin Mohammed Kamel is a senior executive at Dallah Al Baraka Holding Company (a major shareholder in Dallah Healthcare Company and owner of Darin Travel and Tourism Agency). The transactions relate to employee travel tickets, with total transactions for 2024 amounting to SAR 8,777,731. It is noted that there are no preferential terms under the contract (Attached).

13- Vote on the business and contracts concluded between the company and Khalid Al-Faqih Engineering Consultancy Office, in which Board Member Dr. Mohammed bin Rashid Al-Faqih has an indirect interest as the brother of Eng. Khalid Al-Faqih. The contract pertains to the provision of engineering consultancy services, with total transactions for 2024 amounting to SAR 1,479,707. It is noted that there are no preferential terms under the contract (Attached).

14- Vote on the business and contracts concluded between the company and Jarir Marketing Company, in which Board Member Mr. Fahad bin Abdullah AlKassim has an indirect interest as a board member of Jarir Marketing Company. The contract pertains to the supply of office equipment and stationery, with total transactions for 2024 amounting to SAR 83,027. It is noted that there are no preferential terms under the contract (Attached).

15- Vote on the business and contracts concluded between the company and Wahet Al-Nakheel Real Estate Fund, in which the Vice Chairman, Mr. Mohiuddin bin Saleh Kamel, has an indirect interest as Vice Chairman and shareholder of Dallah Real Estate Company, one of the unit holders in the Fund. The transaction relates to the sale of lands owned by Dallah Healthcare Company located in Al-Nakheel District to the Wahet Al-Nakheel Real Estate Fund, in exchange for the issuance of in-kind units in the fund in addition to a cash portion. The arrangement extends over five years and is renewable, with a total in-kind value of SAR 195,652,315 and a cash portion amounting to SAR 8,695,370, with no preferential terms (Attached).

16- Vote on authorizing the Chairman, Eng. Tariq bin Othman Al Qasabi, to engage in a competing business by serving as a board member of International Medical Center Company (a closed joint-stock company) engaged in healthcare services (Attached).

17- Vote on authorizing the Vice Chairman, Mr. Mohiuddin bin Saleh Kamel, to engage in a competing business by serving as Vice Chairman of the Board of International Medical Center Company (a closed joint-stock company) engaged in healthcare services (Attached).

18- Vote on authorizing Board Member Mr. Fahad bin Abdullah AlKassim to engage in a competing business by serving as a board member of Dr. Mohammed Rashid Al-Faqih & Partners Company (a closed joint-stock company) engaged in healthcare services (Attached).

19- Vote on authorizing Board Member Dr. Mohammed bin Rashid Al-Faqih to engage in a competing business through his direct ownership of 18.20% in Dr. Mohammed Rashid Al-Faqih & Partners Company (a closed joint-stock company) engaged in healthcare services (Attached).

20- Vote on authorizing Board Member Dr. Mohammed bin Rashid Al-Faqih to engage in a competing business by serving as Chairman of Dr. Mohammed Rashid Al-Faqih & Partners Company (a closed joint-stock company) engaged in healthcare services (Attached).

21- Vote on authorizing the Board of Directors to distribute interim dividends on a semi-annual or quarterly basis for the fiscal year 2025.

22- Vote on the delegating the authority of the General Assembly to the Board of Directors with the license contained in Paragraph (1) of Article Twenty-Seven of the Companies Law, for a period of one year from the date of the General Assembly’s approval or until the end of the delegated Board of Directors’ session, whichever comes first, in accordance with the conditions contained in the executive regulations of the Law Private companies of listed joint stock companies.

Proxy Form
The shareholder right in discussing the assembly agenda topics, asking questions, and exercising the voting right Shareholders have the right to discuss the topics listed in the agenda of the General Assembly and raise relevant questions and inquiries.

Registering and voting in Tadawulaty platform is free and available to all shareholders via the following link: www.tadawulaty.com.sa.

Details of the electronic voting on the Assembly’s agenda Shareholders registered in Tadawulaty services will be able to vote electronically on the general assembly’s agenda. Electronic voting will start Sunday at 1:00AM, 27/11/1446 AH Corresponding to 25/05/2025, until the end of the vote tallying by the votes collection committee
Method of Communication in Case of Any Enquiries In case of any inquiries or questions regarding the meeting schedule, please contact the Investors Relations Department:

Telephone: +966 11 2255065 (5769)

Fax: +966 11 4550803

Email: IR@Dallahhealth.com

Attached Documents   

Comments